Free Trial
→ Read this warning immediately (From Porter & Company) (Ad)tc pixel Free CMMB Stock Alerts

Chemomab Therapeutics (CMMB) Stock Chart & Stock Price History

Chemomab Therapeutics logo
$1.54 -0.12 (-6.97%)
As of 11:28 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Chemomab Therapeutics Stock Price Performance

The Chemomab Therapeutics (CMMB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 68.02%, with a year-to-date return of -6.97%. In the past month, the stock has decreased 7.53%, reflecting recent market activity.

As of the latest close, Chemomab Therapeutics traded at $1.65 with a market cap of $11.88 million and volume of 64,040 shares. Five years ago, the stock traded at a split-adjusted price of $86.52, representing a 98.23% decrease over that period. At the time, it had a market cap of $231.40 million and a volume of 373,946 shares.

Receive CMMB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-12.29%
1 Month
Performance
-7.53%
3 Month
Performance
-16.12%
Year-To-Date
Performance
-6.97%
1 Year
Performance
-68.02%
5 Year
Performance
-98.23%

CMMB Stock Chart for Monday, June, 15, 2026

CMMB Chart by TradingView

Chemomab Therapeutics Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
06/12/2026$1.78$1.65
-7.30%		$1.85$1.6564,040 shs$11.88 million
06/11/2026$1.75$1.78
+1.71%		$1.83$1.7212,324 shs$12.82 million
06/10/2026$1.73$1.75
+1.16%		$1.85$1.6910,265 shs$12.60 million
06/09/2026$1.81$1.73
-4.42%		$1.85$1.7129,038 shs$12.46 million
06/08/2026$1.77$1.81
+2.26%		$1.89$1.7611,387 shs$12.73 million
06/05/2026$1.80$1.77
-1.67%		$1.89$1.7041,870 shs$12.73 million
06/04/2026$1.72$1.80
+4.65%		$1.84$1.7131,693 shs$12.94 million
06/03/2026$1.74$1.72
-1.15%		$1.80$1.6815,997 shs$12.37 million
06/02/2026$1.86$1.74
-6.45%		$1.95$1.7469,418 shs$13.38 million
06/01/2026$2.00$1.86
-7.00%		$2.08$1.86110,441 shs$13.37 million
05/29/2026$2.07$2.00
-3.38%		$2.09$1.9671,609 shs$14.38 million
05/28/2026$1.90$2.07
+8.95%		$2.08$1.9138,270 shs$14.88 million
05/27/2026$2.03$1.90
-6.40%		$2.02$1.9030,844 shs$13.67 million
05/26/2026$2.02$2.03
+0.50%		$2.14$1.9456,116 shs$14.60 million
05/25/2026$2.02$2.02$2.09$1.8390,067 shs$14.52 million
05/22/2026$1.82$2.02
+10.99%		$2.09$1.8390,067 shs$14.52 million
05/21/2026$1.66$1.82
+9.64%		$1.87$1.6781,211 shs$13.09 million
05/20/2026$1.55$1.66
+7.10%		$1.69$1.5521,972 shs$11.94 million
05/19/2026$1.62$1.55
-4.32%		$1.68$1.5440,154 shs$11.14 million
05/18/2026$1.66$1.62
-2.41%		$1.71$1.6128,951 shs$11.65 million
05/15/2026$1.70$1.66
-2.35%		$1.73$1.646,530 shs$11.94 million
05/14/2026$1.74$1.70
-2.30%		$1.80$1.6445,036 shs$12.22 million
Related Companies

This page (NASDAQ:CMMB) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel